References
WHO: SIXTY-THIRD WORLD HEALTH ASSEMBLY A63/23 Provisional agenda item 11.20 22 April 2010, Counterfeit medical products Report by the Secretariat
Al-Worafi, Y M. (2020, November 5). Counterfeit and substandard medications. https://www.sciencedirect.com/science/article/pii/B9780128198377000108
Cabezas, M D. (2010, January 1). Counterfeit medicines as a global treat. Pharmaceuticals, policy and law, 12(3,4), 179-192. https://doi.org/10.3233/ppl-2010-0304
SF, I. (2020, April 6). A study on the public health and socioeconomic impact of substandard and falsified medical products. https://www.who.int/publications/i/item/9789241513432
Glass, B. (2014, March 1). Counterfeit drugs and medical devices in developing countries. https://doi.org/10.2147/rrtm.s39354Mackey,
T K., & Liang, B A. (2011, June 22). The global counterfeit drug trade: patient safety and public health risks.. https://jpharmsci.org/retrieve/pii/S002235491531858X
